Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7Q1W | A7B6A6 | Ruminococcus gnavus ATC29149 endo-beta-1,4-galactosidase (RgGH98) E411A in complex with blood group A (BgA II) tetrasaccharide | |
| 7Q1P | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide | |
| 7Q1O | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide | |
| 7Q1N | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide | |
| 7Q1M | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide | |
| 7Q1L | P02787 | Glycosilated Human Serum Apo-tranferrin | |
| 7Q1K | G3XAP7 | Crystal structure of the native AA9A LPMO from Thermoascus aurantiacus | |
| 7Q15 | P55899 | Crystal structure of FcRn and beta-2-microglobulin in complex with IgG1-Fc-MST-HN (efgartigimod) | |
| 7Q15 | P61769 | Crystal structure of FcRn and beta-2-microglobulin in complex with IgG1-Fc-MST-HN (efgartigimod) | |
| 7Q15 | 7Q15 | Crystal structure of FcRn and beta-2-microglobulin in complex with IgG1-Fc-MST-HN (efgartigimod) | |
| 7Q13 | P13807 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate, uridine diphosphate, and glucose | |
| 7Q13 | P46976 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate, uridine diphosphate, and glucose | |
| 7Q12 | P13807 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate | |
| 7Q12 | P46976 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate | |
| 7Q0S | P13807 | Human GYS1-GYG1 complex inhibited-like state bound to glucose-6-phosphate | |
| 7Q0S | P46976 | Human GYS1-GYG1 complex inhibited-like state bound to glucose-6-phosphate | |
| 7Q0I | 7Q0I | Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43 | |
| 7Q0I | P0DTC2 | Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43 | |
| 7Q0H | 7Q0H | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-50 and Beta-54 | |
| 7Q0H | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-50 and Beta-54 | |
| 7Q0G | 7Q0G | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-49 and FI-3A Fabs | |
| 7Q0G | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-49 and FI-3A Fabs | |
| 7Q0A | P0DTC2 | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | 7Q0A | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | Q3I5J5 | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | P0DTC2 | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | 7Q0A | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7Q0A | Q3I5J5 | SARS-CoV-2 Spike ectodomain with Fab FI3A | |
| 7PZ8 | G3XAP7 | Structure of an LPMO at 3.12x10^6 Gy | |
| 7PZ7 | G3XAP7 | Structure of an LPMO at 1.13x10^6 Gy | |
| 7PZ6 | G3XAP7 | Structure of an LPMO at 2.22x10^5 Gy | |
| 7PZ5 | G3XAP7 | Structure of an LPMO at 9.56x10^4 Gy | |
| 7PZ4 | G3XAP7 | Structure of an LPMO at 2.07x10^4 Gy | |
| 7PZ3 | G3XAP7 | Structure of an LPMO at 5.37x10^3 Gy | |
| 7PZ0 | A0A0S2GKZ1 | Structure of LPMO (expressed in E.coli) with cellotriose at 9.81x10^6 Gy | |
| 7PYZ | A0A0S2GKZ1 | Structure of LPMO (expressed in E.coli) with cellotriose at 2.97x10^6 Gy | |
| 7PYY | A0A0S2GKZ1 | Structure of LPMO (expressed in E.coli) with cellotriose at 5.05x10^5 Gy | |
| 7PYX | A0A0S2GKZ1 | Structure of LPMO (expressed in E.coli) with cellotriose at 2.74x10^5 Gy | |
| 7PYW | A0A0S2GKZ1 | Structure of LPMO (expressed in E.coli) with cellotriose at 5.62x10^4 Gy | |
| 7PYU | A0A0S2GKZ1 | Structure of an LPMO (expressed in E.coli) at 1.49x10^4 Gy | |
| 7PYI | A0A0S2GKZ1 | Structure of LPMO in complex with cellotetraose at 6.65x10^6 Gy | |
| 7PYH | A0A0S2GKZ1 | Structure of LPMO in complex with cellotetraose at 1.45x10^6 Gy | |
| 7PYG | A0A0S2GKZ1 | Structure of LPMO in complex with cellotetraose at 3.6x10^5 Gy | |
| 7PYF | A0A0S2GKZ1 | Structure of LPMO in complex with cellotetraose at 1.39x10^5 Gy | |
| 7PYE | A0A0S2GKZ1 | Structure of LPMO in complex with cellotetraose at 5.99x10^4 Gy | |
| 7PYD | A0A0S2GKZ1 | Structure of LPMO in complex with cellotetraose at 7.88x10^3 Gy | |
| 7PY4 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited state | |
| 7PY4 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited state | |
| 7PXW | A0A0S2GKZ1 | LPMO, expressed in E.coli, in complex with Cellotetraose | |
| 7PXV | A0A0S2GKZ1 | LsAA9_A chemically reduced with ascorbic acid (high X-ray dose) |
